Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

830 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Extracellular vesicles containing SARS-CoV-2 proteins are associated with multi-organ dysfunction and worse outcomes in patients with severe COVID-19.
de Miguel-Perez D, Arroyo-Hernandez M, La Salvia S, Gunasekaran M, Pickering EM, Avila S, Gebru E, Becerril-Vargas E, Monraz-Perez S, Saharia K, Grazioli A, McCurdy MT, Frieman M, Miorin L, Russo A, Cardona AF, García-Sastre A, Kaushal S, Hirsch FR, Atanackovic D, Sahoo S, Arrieta O, Rolfo C. de Miguel-Perez D, et al. Among authors: garcia sastre a. J Extracell Vesicles. 2024 Nov;13(11):e70001. doi: 10.1002/jev2.70001. J Extracell Vesicles. 2024. PMID: 39558820 Free PMC article.
Unambiguous detection of SARS-CoV-2 subgenomic mRNAs with single cell RNA sequencing.
Cohen P, DeGrace EJ, Danziger O, Patel RS, Barrall EA, Bobrowski T, Kehrer T, Cupic A, Miorin L, García-Sastre A, Rosenberg BR. Cohen P, et al. bioRxiv [Preprint]. 2023 Feb 23:2021.11.22.469642. doi: 10.1101/2021.11.22.469642. bioRxiv. 2023. Update in: Microbiol Spectr. 2023 Sep 7:e0077623. doi: 10.1128/spectrum.00776-23 PMID: 34845443 Free PMC article. Updated. Preprint.
Global siRNA Screen Reveals Critical Human Host Factors of SARS-CoV-2 Multicycle Replication.
Yin X, Pu Y, Yuan S, Pache L, Churas C, Weston S, Riva L, Simons LM, Cisneros WJ, Clausen T, De Jesus PD, Kim HN, Fuentes D, Whitelock J, Esko J, Lord M, Mena I, García-Sastre A, Hultquist JF, Frieman MB, Ideker T, Pratt D, Martin-Sancho L, Chanda SK. Yin X, et al. bioRxiv [Preprint]. 2024 Jul 10:2024.07.10.602835. doi: 10.1101/2024.07.10.602835. bioRxiv. 2024. PMID: 39026801 Free PMC article. Preprint.
Characteristics of Lung Cancer Patients With Asymptomatic or Undiagnosed SARS-CoV-2 Infections.
Somisetty M, Mack PC, Hsu CY, Huang Y, Gomez JE, Rodilla AM, Cagan J, Tavolacci SC, Carreño JM, Brody R, Moore AC, King JC, Rohs NC, Rolfo C, Bunn PA, Minna JD, Bhalla S, Krammer F, García-Sastre A, Figueiredo JC, Kazemian E, Reckamp KL, Merchant AA, Nadri M, Ahmed R, Ramalingam SS, Shyr Y, Hirsch FR, Gerber DE. Somisetty M, et al. Clin Lung Cancer. 2024 Nov;25(7):612-618. doi: 10.1016/j.cllc.2024.07.007. Epub 2024 Jul 20. Clin Lung Cancer. 2024. PMID: 39122606
Nirmatrelvir and molnupiravir maintain potent in vitro and in vivo antiviral activity against circulating SARS-CoV-2 omicron subvariants.
Rosales R, McGovern BL, Rodriguez ML, Leiva-Rebollo R, Diaz-Tapia R, Benjamin J, Rai DK, Cardin RD, Anderson AS; PSP study group; Sordillo EM, van Bakel H, Simon V, García-Sastre A, White KM. Rosales R, et al. Antiviral Res. 2024 Oct;230:105970. doi: 10.1016/j.antiviral.2024.105970. Epub 2024 Jul 25. Antiviral Res. 2024. PMID: 39067667
Measurement of circulating viral antigens post-SARS-CoV-2 infection in a multicohort study.
Swank Z, Borberg E, Chen Y, Senussi Y, Chalise S, Manickas-Hill Z, Yu XG, Li JZ, Alter G, Henrich TJ, Kelly JD, Hoh R, Goldberg SA, Deeks SG, Martin JN, Peluso MJ, Talla A, Li X, Skene P, Bumol TF, Torgerson TR, Czartoski JL, McElrath MJ, Karlson EW, Walt DR; RECOVER consortium authors. Swank Z, et al. Clin Microbiol Infect. 2024 Dec;30(12):1599-1605. doi: 10.1016/j.cmi.2024.09.001. Epub 2024 Oct 9. Clin Microbiol Infect. 2024. PMID: 39389851
Susceptibility of sheep to experimental co-infection with the ancestral lineage of SARS-CoV-2 and its alpha variant.
Gaudreault NN, Cool K, Trujillo JD, Morozov I, Meekins DA, McDowell C, Bold D, Carossino M, Balaraman V, Mitzel D, Kwon T, Madden DW, Artiaga BL, Pogranichniy RM, Roman-Sosa G, Wilson WC, Balasuriya UBR, García-Sastre A, Richt JA. Gaudreault NN, et al. bioRxiv [Preprint]. 2021 Nov 22:2021.11.15.468720. doi: 10.1101/2021.11.15.468720. bioRxiv. 2021. Update in: Emerg Microbes Infect. 2022 Dec;11(1):662-675. doi: 10.1080/22221751.2022.2037397 PMID: 34816258 Free PMC article. Updated. Preprint.
Trivalent NDV-HXP-S vaccine protects against phylogenetically distant SARS-CoV-2 variants of concern in mice.
González-Domínguez I, Martínez JL, Slamanig S, Lemus N, Liu Y, Lai TY, Carreño JM, Singh A G, Singh B G, Schotsaert M, Mena I, McCroskery S, Coughlan L, Krammer F, García-Sastre A, Palese P, Sun W. González-Domínguez I, et al. bioRxiv [Preprint]. 2022 Mar 22:2022.03.21.485247. doi: 10.1101/2022.03.21.485247. bioRxiv. 2022. Update in: Microbiol Spectr. 2022 Jun 29;10(3):e0153822. doi: 10.1128/spectrum.01538-22 PMID: 35350201 Free PMC article. Updated. Preprint.
Surface-modified measles vaccines encoding oligomeric, fusion-stabilized SARS-CoV-2 spike glycoproteins bypass measles seropositivity, boosting neutralizing antibody responses to omicron and historical variants.
Muñoz-Alía MÁ, Nace RA, Balakrishnan B, Zhang L, Packiriswamy N, Singh G, Warang P, Mena I, Narjari R, Vandergaast R, García-Sastre A, Schotsaert M, Russell SJ. Muñoz-Alía MÁ, et al. bioRxiv [Preprint]. 2022 Dec 16:2022.12.16.520799. doi: 10.1101/2022.12.16.520799. bioRxiv. 2022. Update in: mBio. 2024 Feb 14;15(2):e0292823. doi: 10.1128/mbio.02928-23 PMID: 36561187 Free PMC article. Updated. Preprint.
830 results